Trana Discovery provides a proprietary drug discovery technology platform that enables its partners to discover new treatments of bacterial, viral, and fungal infectious diseases. Our high-throughput assays screen vast libraries of compounds to identify potential drug candidates that work through a novel mechanism of action: inhibition of the target pathogen(s) ability to use an organism-specific transfer RNA (tRNA), essential for propagation.
Trana is now licensing rights to assays, lead chemistries, target pathogens, and indications. Collaboration and licensing agreements for development and commercialization of discoveries are arranged on a case-by-case basis. Exclusive licensing arrangements may be available.